Science
Mechanism of Action
Carnosic acid functions as a direct scavenger of reactive oxygen species (ROS) and modulates key inflammatory pathways, including the inhibition of STAT1 phosphorylation and NF-κB signaling. Notably, it triggers cutaneous wound regeneration by activating TRPA1 ion channels on sensory neurons, which accelerates the transition from inflammation to the proliferative phase of healing.
Research
Clinical Evidence
High confidence0.2%
Key findings
- 01 Topical application at 0.5% demonstrated 90% wound closure compared to 35% in controls, while significantly reducing fibrotic scarring (JCI Insight, 2025).
- 02 Synergistic formulations with ellagic acid have shown a marked reduction in oxidative stress markers and MMP-9, alongside a measurable increase in collagen density (Gazi University).
Transparency
Dusting Analysis
Carnosic acid is frequently present only as a minor constituent of Rosemary extracts. Without standardization, it is often 'dusted' at levels insufficient to trigger the TRPA1 regenerative response seen in clinical literature.
The Formula
Formulation
Stability
Highly sensitive to thermal degradation above 120°C and requires UV-opaque packaging due to photo-instability. It is most stable in lipid macerates and requires specialized delivery systems if used in aqueous environments.
Synergies
- Ellagic Acid
- Tocopherol (Vitamin E)
- Lipid-based delivery systems
Conflicts
- High-heat processing
- Strongly alkaline environments (> pH 8.0)
- Unencapsulated aqueous solutions
Safety
Safety Profile
The 0.2% limit is strictly enforced for leave-on products by the CIR to prevent potential skin sensitization; higher concentrations are generally reserved for rinse-off applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-precision active that offers exceptional regenerative and antioxidant benefits, provided it is formulated within the 0.2% safety threshold and protected from light and heat.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources